Jun
5
2025
Upcoming webinar

Optimizing for faster quality control in cell therapies: leveraging rapid detection methods

Thursday 08:00 PDT / 11:00 EDT / 16:00 BST / 17:00 CEST
Sponsor
Optimizing for faster quality control in cell therapies: leveraging rapid detection methods

Live30 webinars are thirty-minute presentations designed to update you on the latest innovations, applications, and data in a fast yet interactive format.

Tackling common bottlenecks associated with the detection of mycoplasma and sterility in CAR-T cells is crucial for ensuring more accurate and reliable QC testing protocols. Recent innovation in rapid testing methodologies can improve operational efficiency and significantly reduce testing time and labor, leading in turn to reduced turnaround times for cell therapy QA/QC processes.

This webinar will help attendees to understand the latest technological innovations in mycoplasma and sterility testing detection for CAR-T cells. Application data will be shared, including data demonstrating the sensitivity of the SteriSEQ™ and MycoSEQ™ Plus assays, as well as practical advice on how to effectively implement rapid mycoplasma and sterility testing in cell therapy process workflows. Additionally, attendees will hear guidance on meeting regulatory requirements and ensuring compliance in cell therapy manufacturing processes.

Attend this webinar for:

  • An introduction to practical analytical tools, frameworks, and strategies that can be applied immediately to cell therapy manufacturing processes
  • Key areas to target for increasing efficiency in QA/QC processes, including how to optimize workflows and enhance resource utilization
  • Performance data from CAR-T cell therapy applications of novel rapid mycoplasma and sterility testing kits
  • Protocols for incorporating these kits into existing QA/QC workflows and sterility testing regimes, including best practices and troubleshooting tips
Srinath Kashi Ranganath
Srinath Kashi Ranganath
Staff Scientist, Field Applications - Pharma Analytics at Thermo Fisher Scientific

Srinath supports the implementation, optimization, and validation of Thermo Fisher Scientific Pharma Analytics workflows for biomanufacturing processes across various therapeutic modalities. Previously, Srinath served as a Bioassay Scientist and subject matter expert for the development and optimization of assays for residual DNA and other process-related impurities.